December 2021 ACIP Recommendation on Johnson & Johnson Vaccine
This talking points document was developed by the iREACH Subject Matter Experts to provide information on the ACIP recommendation regarding the Johnson & Johnson COVID-19 vaccine.
First Approved Oral Antiviral Pill for COVID-19 Disease
This talking points document, available in Spanish and English, was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide detailed information on the first approved oral antiviral pill for COVID-19 disease.
COVID-19 Treatments
This updated COVID-19 Treatments Talking Points document was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide information on treatments for COVID-19 disease.
FDA Gives Approval to Moderna’s Spikevax COVID-19 Vaccine for Children 6 Months Through 11 years… But Only If at High Risk
On July 9, 2025, the FDA released its decision to approve the supplemental Biologics License Application (BLA) for SPIKEVAX, but only for certain ages at high risk.
How Data Gaps Impact COVID-19 Vaccine Hesitancy
This opinion piece was authored by Dr. Michelle Fiscus, a subject matter expert that consults for AIM. Note: this opinion piece is not an official AIM statement.
Updated COVID-19 Vaccine Booster Doses
Learn more about the two new Omicron (bivalent) vaccines, Pfizer and Moderna, which were recently authorized to be used as booster doses to help protect against the Omicron variants of the virus that causes COVID-19.
Infographic: What Goes Into a Vaccine? Thimerosal Spotlight
This iREACH infographic provides information on ingredients that are used in vaccines, specifically highlighting thimerosal.
New Findings to Support Fully-Considered Decision-Making: Deliberation About Risks and Benefits in the Context of Values
The wave three report of Understanding Diverse Communities and Supporting Equitable and Informed Vaccination Decision-Making been released.
Adolescent Immunization Toolkit
Increasing adolescent vaccination coverage is essential to safeguarding public health and preventing outbreaks of vaccine-preventable diseases. This toolkit offers a selection of resources and insight into activities and strategies to…
2023 AIM Leadership in Action Conference Presentations
View the session descriptions and presentations from the 2023 AIM Leadership in Action Conference.